Physician Assistant · Pittsboro, NC
NPI
1427643386
Since 2021
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
148 Tobacco Rd
Pittsboro, NC, 27312
Phone (919) 604-5179
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
1,351 services
Medicare patients, 2024
206
Average age 67
Drug cost, 2024
$1.1M
8,166 prescriptions
Company payments, 2025
$36.65
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Young III was code 99214 (office e&m - established), 524 times for 185 patients. In total Robert J Young III billed 1,351 services in 8 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 524 | 185 | $55.36 | $29K |
| 80307 Drug Tests | Office | 389 | 155 | $60.90 | $24K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 188 | 75 | $194.77 | $37K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 133 | 69 | $241.98 | $32K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 70 | 32 | $153.46 | $11K |
| 99205 Office E&M - New | Office | 29 | 29 | $119.60 | $3,469 |
By year: 2022 $136K for 1,452 services; 2023 $131K for 1,315 services; 2024 $138K for 1,351 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 389 | 155 | $60.90 | $24K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 188 | 75 | $194.77 | $37K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 133 | 69 | $241.98 | $32K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 70 | 32 | $153.46 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Young III prescribed most often to Medicare patients was Oxycodone Hcl, with 1,561 prescriptions and refills. In total Robert J Young III wrote 8,166 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,561 | 1,561 | 324 | $27K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 816 | 816 | 208 | $70K |
| Morphine Sulfate Er Morphine Sulfate | 615 | 615 | 111 | $21K |
| Gabapentin Generic | 477 | 523 | 127 | $5,894 |
| Xtampza Er Oxycodone Myristate | 467 | 467 | 118 | $331K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 386 | 386 | 108 | $14K |
| Pregabalin Generic | 357 | 373 | 91 | $6,567 |
| Cyclobenzaprine Hcl Generic | 307 | 344 | 94 | $3,392 |
| Tizanidine Hcl Generic | 286 | 322 | 69 | $4,485 |
| Fentanyl Generic | 204 | 204 | 53 | $32K |
| Methadone Hcl Generic | 171 | 171 | 31 | $4,270 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 159 | 159 | 57 | $29K |
| Duloxetine Hcl Generic | 137 | 170 | 45 | $1,419 |
| Oxycontin Oxycodone Hcl | 124 | 124 | 24 | $91K |
| Buprenorphine Hcl Generic | 116 | 116 | 29 | $6,380 |
Brand drugs: - claims; generic drugs: 6,974 claims; opioid claims: 4,936.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Young III $36.65 ($36.65 in general payments such as food, travel and fees) from 2 companies. The largest payer was Valinor Pharma, LLC with $21.06.
| Company | Payments | Amount |
|---|---|---|
| Valinor Pharma, LLC | 1 | $21.06 |
| Virtus Pharmaceuticals LLC | 1 | $15.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.